Origin.

A woman opens an app at her kitchen table, joins a video call, and meets the same physical therapist she saw last week. No waiting room. No surprise bill. Her copay is the price of a sandwich.

That scene used to be science fiction. Pelvic floor physical therapy - the evidence-based treatment for incontinence, painful sex, postpartum pain, prolapse, and the everyday wreckage that pregnancy and menopause can leave behind - existed, mostly, as a cash-pay luxury. Two hundred dollars a session. Three hundred. A specialty you found by accident, if you found it at all. Origin's whole project is to make that scene ordinary.

Today Origin runs 19 brick-and-mortar clinics across seven states and operates the first nationwide virtual pelvic floor PT network in the country. It has treated more than 50,000 patients, taken referrals from over 10,000 physicians, and signed insurance partnerships covering roughly 50 million lives. Ninety-five percent of its care is billed in-network. The company is, by its own count, the largest pelvic floor PT network in America - which is either an impressive feat or a quiet indictment of how small that category used to be. Probably both.

41 million women, and a treatment most never hear about

An estimated 41 million American women live with a pelvic floor condition - ranging from mildly annoying to genuinely debilitating. The treatment that works is not a mystery. Pelvic floor physical therapy has decades of evidence behind it. The mystery is the distribution.

For most of medicine's history, pelvic health got filed under "things women just live with." Leaking when you sneeze. Pain during sex. A core that never quite came back after childbirth. The standard medical answer was a shrug, a Kegel pamphlet, or a referral to a specialist with a three-month waitlist who didn't take insurance. The care existed. Access didn't.

That gap is expensive. Untreated pelvic and musculoskeletal conditions push women toward surgery, imaging, and chronic pain management - the costly end of the system. Origin pegs the savings of fixing this at roughly $65 billion to the American health system. A big number, and one the company is happy to keep repeating.

Built by someone who needed it first

Carine Carmy spent close to a decade dealing with painful sex before a friend - and eventual co-founder - Nona Farahnik Yadegar told her about pelvic floor PT. The treatment changed Carmy's life. The fact that it took ten years to find out it existed changed her career.

In 2020, in the middle of a pandemic that made "virtual healthcare" suddenly unavoidable, Carmy, Farahnik Yadegar, and David Yadegar started Origin. The bet had two parts, and both ran against conventional wisdom. First: that pelvic floor PT could be delivered well over video, not just in person. Second - the harder one - that it should run through insurance instead of cash pay, even though in-network reimbursement is a margin grind that scares off most specialty clinics.

The cash-pay model is easier to operate and far more profitable per visit. Origin chose the harder road on purpose, because a treatment that only rich women can afford isn't really a solution to a 41-million-woman problem.

Hybrid by design, not by accident

Origin treats people 18 and up with vaginal anatomy, across nearly every stage of life: pregnancy and birth prep, postpartum recovery, painful sex, diastasis recti, bladder and bowel control, menopause, prolapse, endometriosis, and surgical recovery. It has also expanded into whole-body musculoskeletal care - chronic back pain, hip pain, frozen shoulder, even de Quervain's tendinitis from carrying a newborn around.

The delivery is deliberately hybrid. Virtual visits for accessibility and continuity; in-person clinics for hands-on work that a webcam can't do. A patient app and the On-Track membership keep the exercises, symptom tracking, and live classes going between sessions. And there's an AI clinical decision-support tool, sensibly named Athena, that helps therapists - rather than replaces them - make evidence-based calls.

Patients, payers, and a few familiar names

The Series B, announced January 28, 2026, was led by SJF Ventures, with The Blue Venture Fund, Gratitude Railroad, and financing from the California Infrastructure and Economic Development Bank. The angel list reads like a femtech reunion: Afton Vechery of Modern Fertility, wellness entrepreneur Hannah Bronfman, and Spring Fertility's Peter Klatsky. The round size went undisclosed - which is its own kind of statement.

Beyond capital, Origin has been wiring itself into the systems people already use. A May 2026 partnership with Carrot Fertility folds pelvic floor care into employer benefits, moving Origin from a place you find on your own to a benefit your job hands you. The proof that matters most, though, is quieter: physician referrals jumped from 1,500 to more than 10,000 in roughly two years. Doctors are cautious referrers. They don't send patients somewhere twice if the first visit went badly.

Boring, on purpose

Origin's ambition isn't to be exotic. It's to make pelvic floor PT so normal that it stops being a story - the way getting your teeth cleaned is not a story. Covered. Routine. Available whether you live in Los Angeles or three hours from the nearest specialist. The company invests in clinical research, runs its own training pipeline, and treats the whole body rather than a single complaint, because the goal is a standard of care, not a boutique.

There's a tension the company can't fully escape, and to its credit it doesn't pretend to. In-network medicine is a margin business. Growing a clinician workforce is slow. Scaling trust in a field built on stigma takes years, not quarters. Origin chose every one of those hard things deliberately. The easy version of this company would have been a cash-pay app with a wellness aesthetic. The useful version is the one that took insurance.

Picture the kitchen table again. The app, the familiar therapist, the copay that costs less than lunch.

Five years ago, that woman likely wouldn't have known pelvic floor PT existed. If she had, she'd have driven across town to a specialist who didn't take her insurance, paid out of pocket, and probably stopped after two visits. Now she finishes her session, books the next one, and gets back to her day. The scene is unremarkable. That's the point - and that's the win.

Origin's bet is that the unremarkable is where real change lives. Not in a breakthrough, but in a treatment that already worked finally reaching the 41 million people who needed it. The future feels good. For a growing number of women, it already does.